Nasopharyngeal Carcinoma
Overview and management of cancer in the nasopharynx.
Reviewed by Dr Kola Tytler MBBS CertHE MBA MRCGP (General Practitioner)
Last reviewed: 21 October 2025
Clinical Guidelines
CKS: Head and neck cancers - recognition and referral
National
ESMO-EURACAN Clinical Practice Guideline: Nasopharyngeal CarcinomaNational
Chemotherapy in Combination With Radiotherapy for Definitive-Intent Treatment of Stage II–IVA Nasopharyngeal Carcinoma: ASCO and CSCO GuidelineLocal
ESMO Clinical Practice Guidelines: Head and Neck CancersLocal
Indian clinical practice consensus guidelines for the management of nasopharyngeal cancer – Update 2024Local
International guideline for the delineation of the clinical target volumes (CTV) for nasopharyngeal carcinomaLocal
International recommendations for plasma Epstein-Barr virus DNA analysis in the management of nasopharyngeal carcinomaLocal
Nasopharyngeal Carcinoma Treatment (PDQ®) – Health Professional VersionLocal
Nasopharyngeal carcinoma: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-upLocal
Nasopharyngeal carcinoma: ESMO–EURACAN Clinical Practice Guideline updateLocal
Nasopharyngeal carcinoma: United Kingdom National Multidisciplinary GuidelinesLocal
Primary Target Volume Delineation for Radiotherapy in Nasopharyngeal Carcinoma: International GuidelineLocal
SEOM clinical guideline in nasopharynx cancer (2017)Local
The Chinese Society of Clinical Oncology (CSCO) clinical guidelines for the diagnosis and treatment of nasopharyngeal carcinomaLocal